Magazine Article | August 2, 2021

A Q&A With A Biotech Founder/Entrepreneur

Source: Life Science Leader

By Dan Schell, Editorial Director, Life Science Leader

While an Entrepreneur in Residence at Atlas Venture, Nello Mainolfi, Ph.D., helped cofound Kymera Therapeutics, a Boston-based clinical-stage biopharmaceutical company focused on targeted protein degradation, a new approach to addressing previously intractable disease targets. Prior to Atlas, he used his training as a chemist to work seven years at the Novartis Institutes for Biomedical Research, where he helped identify more than 10 compounds that have entered preclinical and clinical development.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: